Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris

This study has been completed.

Sponsor:

Information provided by:

Northwestern University

ClinicalTrials.gov Identifier:

NCT00787943

First received: November 6, 2008

Last updated: November 19, 2010

Last verified: November 2010

History of Changes

Results First Received: September 24, 2010

Study Type:	Interventional
Study Design:	Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Treatment
Condition:	Acne Vulgaris
Intervention:	Drug: topical benzoyl peroxide 10.0% cream - Formulations #1 and #2

Participant Flow

Hide Participant Flow

Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Participants were recruited from the clinic, as well as advertising in the Department of Dermatology.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups

	Description
All Study Participants	Apply Formula #1 to assigned side of face twice daily. Apply Formula #2 to assigned side of face twice daily.

Participant Flow: Overall Study

	All Study Participants
STARTED	10
COMPLETED	10
NOT COMPLETED	0

Baseline Characteristics

Hide Baseline Characteristics

Reporting Groups

	Description
All Study Participants	Apply Formula #1 to assigned side of face twice daily. Apply Formula #2 to assigned side of face twice daily.

Baseline Measures

	All Study Participants
Number of Participants [units: participants]	10
Age [units: participants]
<=18 years	0
Between 18 and 65 years	10
>=65 years	0
Gender [units: Participants]
Female	6
Male	4
Region of Enrollment [units: participants]
United States	10

Outcome Measures

1. Primary:

Number of Inflammatory Lesions (Papules and Pustules) [ Time Frame: 4 Weeks ]

Show Outcome Measure 1

Serious Adverse Events

Show Serious Adverse Events

Other Adverse Events

Hide Other Adverse Events

Time Frame	4 weeks
Additional Description	No text entered.

Frequency Threshold

Threshold above which other adverse events are reported	0%

Reporting Groups

	Description
Benzoyl Peroxide 10.0% Cream Formulation #1	Formulation #1 applied to one side of the face by all 10 subjects.
Benzoyl Peroxide 10.0% Cream: Formulation #2	Formulation #2 applied to one side of the face by all 10 subjects.

Other Adverse Events

	Benzoyl Peroxide 10.0% Cream Formulation #1	Benzoyl Peroxide 10.0% Cream: Formulation #2
Total, other (not including serious) adverse events
# participants affected / at risk	8/10	8/10
Skin and subcutaneous tissue disorders
Burning/Stinging ^†
# participants affected / at risk	8/10 (80.00%)	8/10 (80.00%)
# events	40	40

†	Events were collected by systematic assessment

More Information

Hide More Information

Certain Agreements:

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

Results Point of Contact:

Name/Title: Amy Paller, MD
Organization: Northwestern University
phone: 773-327-9642
e-mail: apaller@northwestern.edu

No publications provided

Responsible Party:	Amy Paller, MD, Northwestern University Department of Dermatology
ClinicalTrials.gov Identifier:	NCT00787943 History of Changes
Other Study ID Numbers:	AP-032408
Study First Received:	November 6, 2008
Results First Received:	September 24, 2010
Last Updated:	November 19, 2010
Health Authority:	United States: Institutional Review Board

To Top